Expert perspectives on cholangiocarcinoma (CCA)

Intended for European healthcare professionals only

Cancer of unknown primary (CUP) (2 videos)

Select a category

View all Cancer of unknown primary (CUP) Multidisciplinary team approach in CCA Overview of CCA Precision medicine and molecular profiling in CCA Symposia highlights

The challenges associated with diagnosing intrahepatic cholangiocarcinoma for targeted therapies (ESMO 2022)

Professor Juan Valle

University of Manchester & The Christie, Manchester, UK

Professor Juan Valle

University of Manchester & The Christie, Manchester, UK

Disclosures

Professor Juan Valle:

Company/Organisation	Relationship(s)
Imaging Equipment Ltd, Ipsen, Novartis, NuCana	Speakers bureau
Celgene, NuCana	Travel grant
Agios, AstraZeneca, Debiopharm, Delcath Systems, GenoScience Pharma, Imaging Equipment Ltd, Incyte, Ipsen, Keocyt, Merck, Mundipharma EDO, Novartis, NuCana, PCI Biotech, Pieris Pharmaceuticals, Pfizer, QED, Servier, Wren Laboratories	Grant support

Disclosures

Professor Juan Valle:

Company/Organisation	Relationship(s)
Imaging Equipment Ltd, Ipsen, Novartis, NuCana	Speakers bureau
Celgene, NuCana	Travel grant
Agios, AstraZeneca, Debiopharm, Delcath Systems, GenoScience Pharma, Imaging Equipment Ltd, Incyte, Ipsen, Keocyt, Merck, Mundipharma EDO, Novartis, NuCana, PCI Biotech, Pieris Pharmaceuticals, Pfizer, QED, Servier, Wren Laboratories	Grant support

If you would like to request further medical information, please visit:
www.incyteglobalmedicalinformation.com

This website has been created and funded by Incyte.

If you would like to request further medical information, please visit:
www.incyteglobalmedicalinformation.com